Swiss National Bank Bio Rad Laboratories, Inc. Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Swiss National Bank holds 59,100 shares of BIO stock, worth $19.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
59,100
Previous 58,700 0.68%
Holding current value
$19.9 Million
Previous $16 Million 23.34%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$263.97 - $344.64 $105,588 - $137,856
400 Added 0.68%
59,100 $19.8 Million
Q2 2024

Aug 08, 2024
SELL
$268.26 - $339.48 $1.66 Million - $2.1 Million
-6,200 Reduced 9.55%
58,700 $16 Million
Q1 2024

May 07, 2024
SELL
$304.11 - $351.99 $821,097 - $950,373
-2,700 Reduced 3.99%
64,900 $22.4 Million
Q4 2023

Feb 06, 2024
SELL
$269.37 - $365.04 $915,858 - $1.24 Million
-3,400 Reduced 4.79%
67,600 $21.8 Million
Q3 2023

Nov 08, 2023
SELL
$350.25 - $422.63 $3.01 Million - $3.63 Million
-8,600 Reduced 10.8%
71,000 $25.4 Million
Q2 2023

Aug 09, 2023
SELL
$359.49 - $486.4 $3.09 Million - $4.18 Million
-8,600 Reduced 9.75%
79,600 $30.2 Million
Q1 2023

May 10, 2023
SELL
$418.69 - $503.0 $921,118 - $1.11 Million
-2,200 Reduced 2.43%
88,200 $42.2 Million
Q4 2022

Feb 08, 2023
SELL
$351.71 - $456.01 $2.31 Million - $2.99 Million
-6,565 Reduced 6.77%
90,400 $38 Million
Q3 2022

Nov 09, 2022
SELL
$412.59 - $563.26 $41,259 - $56,326
-100 Reduced 0.1%
96,965 $40.4 Million
Q2 2022

Aug 09, 2022
BUY
$463.67 - $597.16 $139,101 - $179,148
300 Added 0.31%
97,065 $48 Million
Q1 2022

May 09, 2022
BUY
$524.57 - $735.42 $6.4 Million - $8.97 Million
12,200 Added 14.43%
96,765 $54.5 Million
Q4 2021

Feb 08, 2022
SELL
$708.84 - $794.68 $2.55 Million - $2.86 Million
-3,600 Reduced 4.08%
84,565 $63.9 Million
Q3 2021

Nov 08, 2021
SELL
$657.71 - $825.77 $1.91 Million - $2.39 Million
-2,900 Reduced 3.18%
88,165 $65.8 Million
Q2 2021

Aug 06, 2021
BUY
$576.64 - $649.04 $3.15 Million - $3.55 Million
5,465 Added 6.38%
91,065 $58.7 Million
Q1 2021

May 07, 2021
BUY
$547.01 - $662.35 $1.09 Million - $1.32 Million
2,000 Added 2.39%
85,600 $48.9 Million
Q4 2020

Feb 05, 2021
SELL
$510.68 - $643.45 $1.33 Million - $1.67 Million
-2,600 Reduced 3.02%
83,600 $48.7 Million
Q3 2020

Nov 09, 2020
SELL
$454.43 - $535.6 $954,303 - $1.12 Million
-2,100 Reduced 2.38%
86,200 $44.4 Million
Q2 2020

Aug 05, 2020
BUY
$334.87 - $493.06 $502,305 - $739,590
1,500 Added 1.73%
88,300 $39.9 Million
Q1 2020

May 08, 2020
BUY
$320.01 - $409.07 $5.34 Million - $6.83 Million
16,700 Added 23.82%
86,800 $30.4 Million
Q4 2019

Feb 06, 2020
BUY
$319.73 - $374.2 $9.78 Million - $11.4 Million
30,593 Added 77.44%
70,100 $25.9 Million
Q3 2019

Nov 12, 2019
BUY
$304.55 - $345.24 $60,910 - $69,048
200 Added 0.51%
39,507 $13.1 Million
Q2 2019

Aug 02, 2019
BUY
$286.93 - $312.59 $229,544 - $250,071
800 Added 2.08%
39,307 $12.3 Million
Q1 2019

May 10, 2019
BUY
$224.3 - $317.41 $291,590 - $412,633
1,300 Added 3.49%
38,507 $11.8 Million
Q4 2018

Feb 13, 2019
BUY
$220.1 - $309.0 $110,050 - $154,500
500 Added 1.36%
37,207 $8.64 Million
Q2 2018

Aug 09, 2018
BUY
$244.1 - $303.88 $97,640 - $121,552
400 Added 1.1%
36,707 $10.6 Million
Q1 2018

May 04, 2018
BUY
$233.97 - $274.11 $187,176 - $219,288
800 Added 2.25%
36,307 $9.08 Million
Q4 2017

Feb 07, 2018
BUY
$216.94 - $271.3 $173,552 - $217,040
800 Added 2.31%
35,507 $8.47 Million
Q3 2017

Nov 03, 2017
BUY
$212.27 - $242.28 $7.37 Million - $8.41 Million
34,707
34,707 $7.71 Million

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.28B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email